TAOK3 and esophageal squamous cell carcinoma: Considering that TAOK3 promotes ESCC progression in this study dependent on its kinase activity, we look forward to seeking out specific inhibitor for TAOK3 in order to find a way to ameliorate their effects on tumor progression.